Literature DB >> 10196463

Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type.

M Yamamoto-Sasaki1, H Ozawa, T Saito, M Rösler, P Riederer.   

Abstract

Cyclic AMP (cAMP) is disrupted in the brain in dementia of the Alzheimer type (DAT). We investigated whether the cAMP reduction is accompanied by an alteration in the cAMP response element binding protein (CREB) downstream in DAT and control hippocampi. Immunoreactivity of pCREB was significantly decreased in DAT, while total CREB level was unchanged. These findings indicate that impaired cAMP signaling may contribute to the pathophysiology of the disease. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196463     DOI: 10.1016/s0006-8993(99)01220-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  68 in total

1.  Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.

Authors:  Baiyang Sheng; Xinglong Wang; Bo Su; Hyoung-gon Lee; Gemma Casadesus; George Perry; Xiongwei Zhu
Journal:  J Neurochem       Date:  2011-12-08       Impact factor: 5.372

2.  Diminished CRE-Induced Plasticity is Linked to Memory Deficits in Familial Alzheimer's Disease Mice.

Authors:  Nancy Bartolotti; Laura Segura; Orly Lazarov
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 3.  Location, location, location: altered transcription factor trafficking in neurodegeneration.

Authors:  Charleen T Chu; Edward D Plowey; Ying Wang; Vivek Patel; Kelly L Jordan-Sciutto
Journal:  J Neuropathol Exp Neurol       Date:  2007-10       Impact factor: 3.685

4.  Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model.

Authors:  Fang Fang; Xiaochun Chen; Tianwen Huang; Lih-Fen Lue; John S Luddy; Shirley Shidu Yan
Journal:  Biochim Biophys Acta       Date:  2011-10-12

5.  Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease.

Authors:  Shiyong Peng; Diego J Garzon; Monica Marchese; William Klein; Stephen D Ginsberg; Beverly M Francis; Howard T J Mount; Elliott J Mufson; Ahmad Salehi; Margaret Fahnestock
Journal:  J Neurosci       Date:  2009-07-22       Impact factor: 6.167

6.  Evidence of Abeta- and transgene-dependent defects in ERK-CREB signaling in Alzheimer's models.

Authors:  Qiu-Lan Ma; Marni E Harris-White; Oliver J Ubeda; Mychica Simmons; Walter Beech; Giselle P Lim; Bruce Teter; Sally A Frautschy; Greg M Cole
Journal:  J Neurochem       Date:  2007-08-30       Impact factor: 5.372

Review 7.  CREB signals as PBMC-based biomarkers of cognitive dysfunction: A novel perspective of the brain-immune axis.

Authors:  Nancy Bartolotti; Orly Lazarov
Journal:  Brain Behav Immun       Date:  2019-01-12       Impact factor: 7.217

8.  Potent activity of nobiletin-rich Citrus reticulata peel extract to facilitate cAMP/PKA/ERK/CREB signaling associated with learning and memory in cultured hippocampal neurons: identification of the substances responsible for the pharmacological action.

Authors:  Ichiro Kawahata; Masaaki Yoshida; Wen Sun; Akira Nakajima; Yanxin Lai; Naoya Osaka; Kentaro Matsuzaki; Akihito Yokosuka; Yoshihiro Mimaki; Akira Naganuma; Yoshihisa Tomioka; Tohru Yamakuni
Journal:  J Neural Transm (Vienna)       Date:  2013-04-16       Impact factor: 3.575

9.  Indirect regulation of presenilins in CREB-mediated transcription.

Authors:  Hirotaka Watanabe; Miriam J Smith; Elizabeth Heilig; Vassilios Beglopoulos; Raymond J Kelleher; Jie Shen
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

10.  Nuclear calcium signaling controls expression of a large gene pool: identification of a gene program for acquired neuroprotection induced by synaptic activity.

Authors:  Sheng-Jia Zhang; Ming Zou; Li Lu; David Lau; Désirée A W Ditzel; Celine Delucinge-Vivier; Yoshinori Aso; Patrick Descombes; Hilmar Bading
Journal:  PLoS Genet       Date:  2009-08-14       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.